These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Controversy about using calcium antagonists for treatment of coronary disease and hypertension]. Głuszek J; Pawlaczyk-Gabriel K Przegl Lek; 1997; 54(9):597-601. PubMed ID: 9501678 [TBL] [Abstract][Full Text] [Related]
6. Calcium antagonists: when the content does not justify the headline. Jackson G Br J Clin Pract; 1995; 49(6):283-4. PubMed ID: 8554947 [No Abstract] [Full Text] [Related]
7. [Long-term treatment with calcium antagonists: advantageous effects and risks]. van Zwieten PA; Tijssen JG; Lie KI; de Leeuw PW Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2715-21. PubMed ID: 8569884 [No Abstract] [Full Text] [Related]
8. Nifedipine in patients with heart disease. Phillips RA; Krakoff LR Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043 [No Abstract] [Full Text] [Related]
9. The nifedipine scare in hypertension: fact or fiction. Gambhir DS Indian Heart J; 1996; 48(3):227-9. PubMed ID: 8755005 [No Abstract] [Full Text] [Related]
10. The calcium channel blocker controversy - a caution to physicians and pharmacist. Eliot L J Pharm Pharm Sci; 1998; 1(1):13-4. PubMed ID: 10942968 [No Abstract] [Full Text] [Related]
11. Safety of calcium antagonists: more ACTION. Messerli FH; Staessen JA Am J Med; 2005 Dec; 118(12):1418-20. PubMed ID: 16378803 [No Abstract] [Full Text] [Related]
12. [Calcium antagonists--much noise about nothing?]. Oberpichler-Schwenk H Med Monatsschr Pharm; 1995 Dec; 18(12):344-9. PubMed ID: 8569586 [No Abstract] [Full Text] [Related]